A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients
1997

Megestrol Acetate and Ibuprofen for Cancer Cachexia

Sample size: 15 publication Evidence: moderate

Author Information

Author(s): DC McMillan, P O'Gorman, KCH Fearon, CS McArdle

Primary Institution: University Department of Surgery, Royal Infirmary, Glasgow; University Department of Surgery, Royal Infirmary, Edinburgh

Hypothesis

Can down-regulating the acute-phase response using ibuprofen and stimulating appetite with megestrol acetate effectively reverse or halt weight loss in advanced gastrointestinal cancer patients?

Conclusion

The combination of megestrol acetate and ibuprofen may help reverse weight loss in patients with gastrointestinal cancer.

Supporting Evidence

  • Patients showed an overall weight gain of 1.3 kg after treatment.
  • C-reactive protein levels significantly decreased after 6 weeks.
  • Two patients lost weight, while the rest either maintained or gained weight.

Takeaway

This study tested a medicine combination to help cancer patients gain weight. It found that the combination worked for most patients.

Methodology

Fifteen patients with advanced gastrointestinal cancer were given megestrol acetate and ibuprofen for 6 weeks, with measurements taken before and after treatment.

Limitations

The study had a small sample size and did not rule out the possibility that ibuprofen alone could have caused the observed effects.

Participant Demographics

Patients had a median age of 64 years, with 10 males and 5 females, and a median weight loss of 15%.

Statistical Information

P-Value

0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication